Analyst Ratings for Brooklyn ImmunoTherapeutics Inc. (BTX)

BTX Rating Summary

  |   Expand Research on BTX
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 7.8 / 10   Percentile Rank: 82%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/12/2022 Maxim Group Jason McCarthy Downgrade Hold
(Buy)		 N/A
(N/A)		 0.21
(6.42)		 2957.14% Details
6/14/2019 Raymond James Dane Leone New Coverage Market Perform
(N/A)		 N/A
(N/A)		 1.00
(6.42)		 542% Details